Hospital pharmacy — the institutional pharmacy serving inpatient medication management, sterile compounding, clinical pharmacist services, and specialty drug management within hospital systems — creates the institutional market dimension of pharmacy, with the Pharmacy Market reflecting hospital pharmacy as an important commercial and clinical pharmacy segment.

Hospital pharmacy drug expenditure — representing approximately forty percent of total US hospital operating costs on pharmaceuticals — creates the significant institutional drug procurement market. Hospital pharmacy directors' dual responsibility for clinical pharmaceutical care and drug cost management creating the pharmaceutical contracting, formulary management, and generic substitution programs that hospitals use to control the largest controllable operating cost category.

Integrated pharmacy benefit management in health systems — the health systems like Kaiser Permanente, Intermountain Health, and Cleveland Clinic operating own specialty pharmacies capturing specialty drug dispensing revenue — represents the vertical integration strategy that health systems are increasingly pursuing. Health system specialty pharmacy programs generating significant revenue while improving medication management for their patient population.

Robotic dispensing in hospital pharmacy — the central pharmacy automation (BD Rowa, Omnicell), IV robotics (RIVA, PharmASSIST), and bedside automated dispensing (BD Pyxis, Omnicell) creating the automated medication management infrastructure — represents the technology investment that transforms hospital pharmacy from manual dispensing to automated precision.

Do you think health system-owned specialty pharmacies will capture the majority of specialty drug dispensing for their patients, reducing PBM-managed specialty network revenue substantially?

FAQ

What is the hospital pharmacy drug procurement model? Hospital drug procurement: GPO (Group Purchasing Organization — Premier, Vizient, HealthTrust) contracts with manufacturers for volume pricing; hospital pharmacy buyer orders from wholesaler (AmerisourceBergen, Cardinal Health, McKesson) against GPO pricing; formulary committee approves drugs for hospital formulary; generic substitution at highest permissible level; 340B program providing significant discounts for eligible facilities; specialty drug purchasing increasingly through own specialty pharmacy; annual drug spend approximately $300-500 billion total hospital spending.

What is the 340B drug discount program? 340B program: HRSA-administered federal program requiring drug manufacturers to sell outpatient drugs at significantly discounted prices to covered entities (safety-net hospitals, federally qualified health centers, certain HIV clinics); discount approximately twenty to fifty percent below wholesale acquisition cost; hospitals use 340B savings to fund uncompensated care; program has grown dramatically; controversy: some hospitals using 340B primarily for revenue generation rather than care subsidization; reform proposals from pharmaceutical manufacturers challenging 340B contract pharmacy model.

#PharmacyMarket #HospitalPharmacy #340Bprogram #HospitalDrugCost #PharmacyAutomation #SpecialtyPharmacyHealth